Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1127 | 1015 | 1235 | 1096 | 1258 | 2371 |
Fund Return | 12.73% | 1.47% | 23.46% | 3.09% | 4.7% | 9.02% |
Place in category | 433 | 469 | 423 | 244 | 197 | 66 |
% in Category | 83 | 85 | 82 | 54 | 54 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin UK Equity Income Fund W ac | 495.44M | 8.45 | 7.27 | 6.93 | ||
Franklin UK Equity Income Fund W in | 296.86M | 8.43 | 7.26 | 6.92 | ||
GB00B7BXT545 | 213.34M | 6.70 | -1.73 | 6.05 | ||
UK Rising Dividends Fund W acc | 192.96M | 9.45 | 6.49 | 7.54 | ||
Franklin UK Managers Focus Fund S a | 20.72M | -1.26 | 2.58 | 5.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.05B | 9.76 | 7.75 | 6.86 | ||
TB Evenlode Income B Income | 3.27B | 1.89 | 4.27 | 8.35 | ||
UK Equity Income Fund Retail Income | 137.65M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Institutional | 91.65M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Z Accumulatio | 669.78M | 10.40 | 7.25 | 7.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 4.94 | 10,474.0 | 0.00% | |
Unilever | GB00B10RZP78 | 4.64 | 56.06 | -0.67% | |
Royal Dutch Shell PLC B | GB00B03MM408 | 4.60 | - | - | |
GlaxoSmithKline PLC | GB0009252882 | 3.48 | - | - | |
British American Tobacco | GB0002875804 | 3.42 | 2,971.0 | +0.07% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review